HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HSP90AB1 | Heat shock protein 90kDa alpha (cytosolic), class B member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
INTS12 | Integrator complex subunit 12 | Cancer-related genes
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLHL8 | Kelch-like family member 8 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP3K1 | Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MED12 | Mediator complex subunit 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NCOR1 | Nuclear receptor corepressor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
NOTCH1 | Notch 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
OMA1 | OMA1 zinc metallopeptidase | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PCBP1 | Poly(rC) binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
PHF6 | PHD finger protein 6 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PPP6C | Protein phosphatase 6, catalytic subunit | Cancer-related genes Enzymes
| | | | | Expressed in all |
PRDM1 | PR domain containing 1, with ZNF domain | Cancer-related genes Transcription factors
| | | | | Mixed |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
QKI | QKI, KH domain containing, RNA binding | Cancer-related genes
| | | | | Expressed in all |
RAD21 | RAD21 homolog (S. pombe) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
RBM10 | RNA binding motif protein 10 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
RPS15 | Ribosomal protein S15 | Cancer-related genes Ribosomal proteins
| | | | | Expressed in all |
RUNX1 | Runt-related transcription factor 1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
SELP | Selectin P (granule membrane protein 140kDa, antigen CD62) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
SERPINB13 | Serpin peptidase inhibitor, clade B (ovalbumin), member 13 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enriched |
SETD2 | SET domain containing 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SIRT4 | Sirtuin 4 | Cancer-related genes
| | | | | Mixed |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SMC1A | Structural maintenance of chromosomes 1A | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SMC3 | Structural maintenance of chromosomes 3 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SPEN | Spen family transcriptional repressor | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
SRSF2 | Serine/arginine-rich splicing factor 2 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |